ALMS
Alumis Inc. Common Stock
There isn't enough reported data to score ALMS yet.
ALMS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Under pressure | |
| Unavailable |
ALMS's profitability and cash flow are currently under pressure. There isn't enough data to rate its revenue and balance sheet.
ALMS PE Valuation
ALMS has no meaningful PE right now: it lost money over the past year.
ALMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| -- | |
| Limited | |
| Low |
Analysts expect ALMS's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
ALMS Earnings Per Share
ALMS lost $3.33 per share over the past year, about the same as its loss the year before.
ALMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9M | -7.7% |
| Q2 2026 | $1.7M | -38% |
| Q1 2026 | $1.7M | -90% |
ALMS's revenue has slid since its 2025 peak: $2M last quarter, down 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5195% | +385 points |
| Q2 2026 | -8956% | -3685 points |
| Q1 2026 | -5652% | -5069 points |
| Q4 2025 | -5000% | N/A |
| Q3 2025 | -5580% | N/A |
| Q2 2025 | -5272% | N/A |
| Q1 2025 | -584% | N/A |
ALMS's operating margin was −5195% last quarter, up 385 points from the same quarter a year ago.
ALMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$80M | +$30.9M |
| Q2 2026 | -$81.7M | +$25.2M |
| Q1 2026 | -$87.2M | -$6.9M |
| Q4 2025 | -$71.9M | +$3.2M |
| Q3 2025 | -$110.9M | -$26.4M |
| Q1 2025 | -$80.4M | -$36M |
| Q4 2024 | -$75.1M | -$40.2M |
| Q3 2024 | -$84.5M | -$49.1M |
ALMS has burned cash in almost every quarter: −$321M over the past year, against −$373M the year before.
ALMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +1.6M shares |
| 1 year | +24% | +25.2M shares |
| 3 years | +149% | +77.5M shares |
ALMS has 129M diluted shares, up 24% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $13,000 |
| Q2 2023 | — |
| Q1 2023 | $51,000 |
ALMS Net Leverage
ALMS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ALMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.3 | Oversold |
| Stochastic | 2.0 | Oversold |
ALMS's weekly RSI is 25 (oversold) and its Stochastic is 2 (oversold).
ALMS PE vs Healthcare Sector
ALMS has no meaningful PE right now: it lost money over the past year.
ALMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.61 | 7.3% below |
| 20 week MA | $16.0 | 62% below |
| 50 week MA | $19.7 | 69% below |
| 100 week MA | $12.4 | 51% below |
ALMS is in a downtrend: it's below all four of its weekly moving averages, and 51% below its 100-week average.
ALMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $13.3 | $8.06 | -39% |
| 2025 | $8.06 | $11.0 | +36% |
| 2026 YTD | $11.0 | $6.13 | -44% |
ALMS has finished lower in one of the last two years. It's down 44% so far in 2026.